Dr. Phalen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3000 Mack Rd
Fairfield, OH 45014Phone+1 513-870-7024Fax+1 513-965-8091
Summary
- Dr. Timothy Phalen is a radiologist in Fairfield, OH and is affiliated with multiple hospitals in the area, including Mercy Health - Fairfield Hospital, OhioHealth Riverside Methodist Hospital, Mercy Health - St. Charles Hospital, Adena Medical Center, Chillicothe Veterans Affairs Medical Center, Mercy Health - Anderson Hospital, and Mercy Health - Clermont Hospital. He received his medical degree from University of Cincinnati College of Medicine and has been in practice 23 years. He specializes in interventional neuroradiology and vascular & interventional radiology.
Education & Training
University of New Mexico School of MedicineFellowship, Vascular and Interventional Radiology, 1998 - 1999- University of New Mexico School of MedicineResidency, Radiology-Diagnostic, 1994 - 1998
University of Cincinnati College of MedicineClass of 1994
Certifications & Licensure
OH State Medical License 1999 - 2026
NC State Medical License 2022 - 2025
CO State Medical License 2000 - 2011
NM State Medical License 1998 - 1999- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Publications & Presentations
PubMed
- 88 citationsThe CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer modelsBetty Tam, Kevin Chiu, Heekyung Chung, Carine Bossard, John Duc Nguyen
Cancer Letters. 2020-03-31 - The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models.Betty Y Tam, Kevin Chiu, Heekyung Chung, Carine Bossard, John Duc Nguyen
Cancer letters. 2019-09-29 - The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models.Betty Y Tam, Kevin Chiu, Heekyung Chung, Carine Bossard, John Duc Nguyen
Cancer letters. 2019-09-29
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
